EUVIMEDEUVIMED entdecken
Crossref

Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts

Jumreang Tummatorn iD, Ittipat Meewan, Nisachon Khunnawutmanotham, Nitirat Chimnoi, Nutchapong Suwanwong, Warabhorn Rodphon, Charnsak Thongsornkleeb, Jingyue Yang, Somsak Ruchirawat

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Jumreang Tummatorn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, Chulabhorn Research Institute, Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Bang…. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Acetylcholinesterase, Molecular Docking Simulation, Triazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Postdoctoral Research Fund from Chulabhorn Graduate Institute, Thailand Science Research and Innovation (TSRI), Chulabhorn Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the rising prevalence of Alzheimer's disease (AD), there is a pressing need for more effective drugs to treat or manage AD's symptoms. Studies have shown that cholinesterase inhibition can improve cognitive and behavioral symptoms associated with AD, by addressing the cholinergic deficit. Based on the recent development of cholinesterase inhibitors with indoloquinoline and triazole moiety, we rationalized that compounds with an isocryptolepine‐triazole scaffold may also have the same biological targets. In this study, eighteen previously synthesized isocryptolepine‐triazole compounds were assessed for their ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The majority of these compounds demonstrated potent selective AChE inhibition. Furthermore, our molecular docking and molecular dynamic simulation studies reveal that the isocryptolepine and triazole moieties are important for the binding of the compounds with the periphery of the AChE's binding pocket. While reductions in molecular weights and lipophilicities may be necessary to improve their pharmacokinetic properties, this work provides valuable insights for designing future AChE inhibitors, based on the novel isocryptolepine‐triazole scaffold.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsAcetylcholinesteraseMolecular Docking SimulationTriazolesButyrylcholinesteraseHumansStructure-Activity RelationshipMolecular Dynamics SimulationMolecular StructureBinding Sites

Stichwörter der Autor:innen

AcetylcholinesteraseAlzheimer's diseaseCholinesterase inhibitoryIsocryptolepineTriazole

Substanzen

Cholinesterase InhibitorsAcetylcholinesteraseTriazolesButyrylcholinesterase

Autor:innen und Institutionen

  • Laboratory of Medicinal Chemistry, Chulabhorn Research Institute, Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Bangkok, 10400, Thailand.
  • Program in Chemical Sciences, Chulabhorn Graduate Institute, Bangkok, 10210, Thailand.
  • Center for Advanced Therapeutics (CAT), Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Laboratory of Organic Synthesis, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
  • Laboratory of Natural Products, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
  • Hebei Key Laboratory of Applied Chemistry, Hebei Key Laboratory of Nano-biotechnology, Yanshan University, Qinhuangdao, 066004, China.

ORCID-Profile: Jumreang Tummatorn

Förderung

  • Postdoctoral Research Fund from Chulabhorn Graduate Institute
  • Thailand Science Research and Innovation (TSRI)
  • Chulabhorn Research Institute
  • National Research Council of Thailand (NRCT)
  • Chulabhorn Graduate Institute
  • Chulabhorn Research Institute, Mahidol University, and the Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Ministry of Education
  • Ministry of Higher Education, Science, Research and Innovation, Thailand
  • Chulabhorn Graduate Institute, Chulabhorn Royal Academy

Zitieren

APA

Tummatorn, J., Meewan, I., Khunnawutmanotham, N., Chimnoi, N., Suwanwong, N., Rodphon, W., Thongsornkleeb, C., Yang, J., & Ruchirawat, S. (2024). Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts. ChemMedChem. https://doi.org/10.1002/cmdc.202400447

Vancouver

Tummatorn J, Meewan I, Khunnawutmanotham N, Chimnoi N, Suwanwong N, Rodphon W, et al. Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts. ChemMedChem. 2024. doi:10.1002/cmdc.202400447

BibTeX
@article{Tummatorn2024,
  author = {Tummatorn, Jumreang and Meewan, Ittipat and Khunnawutmanotham, Nisachon and Chimnoi, Nitirat and Suwanwong, Nutchapong and Rodphon, Warabhorn and Thongsornkleeb, Charnsak and Yang, Jingyue and Ruchirawat, Somsak},
  title = {Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400447}
}
Kostenlos starten →